Low Sickle Cell Disease Mortality In Belgium and Benefit From Hydroxyurea Therapy

被引：0
|
作者：
Le, Phu-Quoc
Dedeken, Laurence
Gulbis, Beatrice
Vermylen, Christiane
Vanderfaeillie, Anna
Heijmans, Catherine
Devalck, Christine
Huybrechts, Sophie
Benghiat, Samantha
Efira, Andre
Dresse, Marie-Francoise
Dupont, Sophie
Ferster, Alina
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
10.1182/blood.V122.21.2231.2231
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2231
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Hydroxyurea for Children with Sickle Cell Disease
    Heeney, Matthew M.
    Ware, Russell E.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2010, 24 (01) : 199 - +
  • [32] Hydroxyurea (hydroxycarbamide) for sickle cell disease
    Nevitt, Sarah J.
    Jones, Ashley P.
    Howard, Jo
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (04):
  • [33] Hydroxyurea therapy lowers TCD velocities in children with sickle cell disease
    Kratovil, Tonya
    Bulas, Dorothy
    Driscoll, M. Catherine
    Speller-Brown, Barbara
    McCarter, Robert
    Minniti, Caterina P.
    PEDIATRIC BLOOD & CANCER, 2006, 47 (07) : 894 - 900
  • [34] Consent, compliance, toxicity and efficacy of hydroxyurea therapy in sickle cell disease
    Hilliard, LM
    Schwartz, J
    Collins, HC
    Howard, TH
    PEDIATRIC RESEARCH, 2003, 53 (04) : 277A - 277A
  • [35] ERYTHROPOIESIS RESPONSE MARKERS TO HYDROXYUREA THERAPY IN PATIENTS WITH SICKLE CELL DISEASE
    Chalvatzi, K.
    Nikolaidou, A.
    Pantelidou, D.
    Chalkia, P.
    Diza, E.
    HAEMATOLOGICA, 2012, 97 : 704 - 705
  • [36] EXPERIMENTAL-THERAPY OF SICKLE-CELL DISEASE - USE OF HYDROXYUREA
    CHARACHE, S
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1994, 16 (01): : 62 - 66
  • [37] IMPACT OF HYDROXYUREA THERAPY ON ALBUMINURIA AMONG CHILDREN WITH SICKLE CELL DISEASE
    Tehseen, Sarah
    Yee, Marianne
    Joiner, Clinton
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S43 - S43
  • [38] Is Low Dose Hydroxyurea the Solution to the Global Epidemic of Sickle Cell Disease?
    Strouse, John J.
    PEDIATRIC BLOOD & CANCER, 2015, 62 (06) : 929 - 930
  • [39] Mutagenicity of hydroxyurea in lymphocytes from patients with sickle cell disease
    Khayat, AS
    Guimaraes, AC
    Cardoso, PC
    de Lima, PDL
    Bahia, MD
    Antunes, LMG
    Burbano, RR
    GENETICS AND MOLECULAR BIOLOGY, 2004, 27 (01) : 115 - 117
  • [40] Optimizing hydroxyurea therapy for sickle cell anemia
    Ware, Russell E.
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 436 - 443
12345